Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_assertion type Assertion NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_head.
- NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_assertion wasGeneratedBy ECO_0000218 NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_provenance.
- NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_assertion wasDerivedFrom ctd_human-2016 NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_provenance.
- NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_assertion SIO_000772 1884014 NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_provenance.
- NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_assertion evidence source_evidence_curated NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_provenance.
- NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_assertion description "[A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP22641.RACq5iPcKSkzM2AAocs3ZnhH1Xl0WUrd01GWVreSqA96U130_provenance.